Chernivtsi Regional Clinical Oncology Center, Day Care Unit

Chernivtsi 58013

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer With Low to Intermediate HER2 Expression, Chemotherapy-Induced Nausea and Vomiting

Studies at this site

• A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting — Completed
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed